Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8

Translational Research

Volumn 155, Issue 1, 2010, Pages 35-43

  Carpagnano, Giovanna E ^a   Spanevello, Antonio ^b   Sabato, Roberto ^a   Depalo, Annarita ^a   Palladino, Grazia P ^a   Bergantino, Laura ^a   Foschino Barbaro, Maria P ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; OXYHEMOGLOBIN;

ADULT; ARTICLE; BODY MASS; BREATH ANALYSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME IMMUNOASSAY; EOSINOPHIL COUNT; EPWORTH SLEEPINESS SCALE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LYMPHOCYTE COUNT; MACROPHAGE; MALE; NECK; NEUTROPHIL COUNT; OBESITY; OXYGEN SATURATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SLEEP APNEA SYNDROME; SPUTUM ANALYSIS;

EID: 71249089214     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2009.09.004     Document Type: Article

References (44)

1. Young T., Palta M., Dempesey J., Skatrud J., Weber S., and Badr S. The occurence of sleep disordered breathing among middle aged adults. N Engl J Med 328 (1993) 1230-1235
2. Ryan S., Taylor C.T., and McNicholas W.T. Predictors of elevated nuclear factor-kB-dependent genes in obstructive sleep apnoea syndrome. Am J Respir Crit Care Med 174 (2006) 824-830
3. Devouassoux G., Levy P., Rossini E., et al. Sleep apnea is associated with bronchial inflammation and continuous positive airway pressure-induced airway hyperresponsiveness. J Allergy Clin Immunol 119 (2007) 597-603
4. Ohga E., Nagase T., Tomita T., et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnoea syndrome. J Appl Physiol 87 (1999) 10-14
5. Arnould T., Michiels C., and Remacle J. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b and ICAM 1. Am J Physiol Cell Physiol 264 (1993) C1102-C1110
6. Combe C., Burton C.J., Dufouco P., et al. Hypoxia induces intercellular adhesion molecule-1 on cultured human tubular cells. Kidney Int 51 (1997) 1703-1709
7. Wilson S.J., Wallin A., Della-Cioppa G., Sandström T., and Holgate S.T. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules and cytokines in asthma. Am J Respir Crir Care Med 164 (2001) 1047-1052
8. Zünd G., Uezono S., Stahl G.L., et al. Hypoxia enhances induction of endhotelial ICAM-1: role for metabolic acidosis and proteasomes. Am J Physiol Cell Physiol 273 (1997) C1571-C1580
9. Barton R.W., Rothlein R., Ksiazek J., and Kennedy C. The effect of anti intercellular adhesion molecule 1 on phorbol-ester induced rabbit lung inflammation. J Immunol 143 (1989) 1278-1282
10. Noda A., Okada T., Hayashi H., Yasuma F., and Yokota M. 24-hour ambulatory blood pressure variability in obstructive sleep apnea syndrome. Chest 103 (1993) 1343-1347
11. Ridker P.M., Hennekens C.K., Buring J.E., and Rifai N. C reactive protein and other markers of inflammation in the prediction of cardiovascular disease in woman. N Engl J Med 342 (2000) 836-843
12. Danesh J., Whincup P., Walkers M., et al. Low grade inflammation and coronary heart disease: prospective study and update meta-analyses. BMJ 321 (2000) 199-204
13. Kageyama N., Nomura M., Nakaya Y., Watanabe T., and Ito S. Relationship between adhesion molecules with hs-CRP and changes therein after ARB (Valsartan) administration in patients with obstructive sleep apnea syndrome. J Med Invest 53 (2006) 134-139
14. Kyzer S., and Charuzi I. Obstructive sleep apnoea in the obese. World J Surg 22 (1998) 998-1001
15. Parish J.M., and Somers V.K. Obstructive sleep apnoea and cardiovascular disease. Mayo Clin Proc 79 (2004) 1036-1046
16. Hartmann G., Tschop M., Fischer R., et al. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 12 (2000) 246-252
17. Sabato R., Guido P., Salerno F.G., Resta O., Spanevello A., and Barbaro M.P. Airway inflammation in patients affected by obstructive sleep apnoea. Monaldi Arch Chest Dis 65 (2006) 102-105
18. Carpagnano G.E., Kharitonov S.A., Resta O., Foschino-Barbaro M.P., Gramiccioni E., and Barnes P.J. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnoea patients. Chest 122 (2002) 1162-1167
19. Depalo A., Carpagnano G.E., Spanevello A., et al. Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects. J Intern Med 263 (2008) 70-78
20. Carpagnano G.E., Spanevello A., Sabato R., Depalo A., Turchiarelli V., and Foschino Barbaro M.P. Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnoea syndrome. Trans Res 151 (2008) 45-50
21. Krishna M.T., Madden J., Teran L.M., et al. Effects of 0.2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid and bronchial mucosa of healthy subjects. Eur Repir J 11 (1998) 1294-1300
22. Lund K., Dunster C., Ramis I., et al. Inflammatoy markers in bronchoalveolar lavage fluid from human volunteers 2 hours after hydrogen fluoride exposure. Hum Exp Toxicol 24 (2005) 101-108
23. Buron E., Garrote J.A., Arranz E., Oyágüez P., Fernández Calvo J.L., and Blanco Quirós A. Markers of pulmonary inflammation in tracheobronchial fluid of premature infants with respiratory distress syndrome. Allergol Immunopathol 27 (1999) 11-17
24. Shi H.Z., Chen Y.Q., and Qin S.M. Inhaled IL-5 increases concentrations of soluble intracellular adhesion molecule-1 in sputum from atopic asthmatic subjects. J Allergy Immunol 103 (1999) 463-467
25. Beeh K.M., Beier J., Kornmann O., and Buhl R. Neutrophilic inflammation in induced sputum of patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 20 (2003) 138-143
26. Vgontzas A.N., Papanicolau D.A., Bixler E.O., Kales A., Tyson K., and Chrousos G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness; role of sleep disturbance and obesity. J Clin Endocrinol Metab 82 (1997) 1313-1316
27. Marin J.M., Carrizo S.J., Vicente E., and Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 (2005) 1046-1053
28. Herder C., Schneitler S., Rathmann W., et al. Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab 92 (2007) 4569-4574
29. Miller M.R., Hanidson J., Brusasco V., et al. Standardisation of spirometry. ATS/ERS standardization of lung function testing: standardization of spirometry. Eur Respir J 26 (2006) 319-338
30. Spanevello A., Confalonieri M., Sulotto F., et al. Induced sputum cellularity. Am J Respir Crit Care Med 162 (2000) 1172-1174
31. LouiseO'Brein M., Laura D., and Gozal D. Plasma adhesion molecules in children with sleep disordered breathing. Chest 129 (2006) 947-953
32. Willerson J.T., and Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 109 (2004) II2-II10
33. Glass C.K., and Witztum J.L. Atherosclerosis: the road ahead. Cell 104 (2001) 503-516
34. Wilcox I., McNamara S.G., Collins F.L., Grunstein R.R., and Sullivan C.E. "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 53 (1998) S25-S28
35. Hein H. Cardiovascular disease and sleep-disordered breathing. Pneumologie 58 (2004) 505-509
36. Ohga E., Nagase T., Tomita T., et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Phisiol 87 (1999) 10-14
37. El-Solh A.A., Mador M.J., Sikka P., Dhillon R.S., Amsterdam D., and Grant B.J. Adhesion molecules in patients with coronary artery disease and moderate to severe obstructive sleep apnoea. Chest 121 (2002) 1541-1547
38. Ursavas A., Karadag M., Rodoplu E., Yilmaztepe A., Oral H.B., and Gözü R.O. Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnoea syndrome. Respiration 74 (2007) 525-532
39. El-Solh A.A., Mador J., Dhillon R.S., Amsterdam D., and Grant B.J. Adhesion molecules in patients with coronary artery disease and moderate to severe obstructive sleep apnoea. Chest 121 (2002) 1541-1547
40. Schulz R., Mahmoudi S., Hattar K., et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 159 (1999) A527
41. Vgontzas A.N. Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance?. Arch Physiol Biochem 114 (2008) 211-223
42. Perrini S., Leonardini A., Laviola L., and Giorgino F. Biological specificity of visceral adipose tissue and therapeutic intervention. Arch Physiol Biochem 114 (2008) 277-286
43. Salerno F., Carpagnano G.E., and Guido P. Airways inflammation in patients affected by osbructive sleep apnea syndrome. Respir Med 98 (2004) 25-28
44. Olopade C.O., Christon J.A., Zakkar M., et al. Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 111 (1997) 1500-1504